SORRENTO THERAPEUTICS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!About SRNE
Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments.
CEOHenry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1989
Founded1989
Employees—
Employees—
SRNE Key Statistics
Market cap2.15M
Market cap2.15M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume560.25K
Average volume560.25K
High today$0.0059
High today$0.0059
Low today$0.0037
Low today$0.0037
Open price$0.0037
Open price$0.0037
Volume1.64M
Volume1.64M
52 Week high$0.0985
52 Week high$0.0985
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
With a market cap of 2.15M, SORRENTO THERAPEUTICS(SRNE) trades at $0.01.
On 2025-12-13, SORRENTO THERAPEUTICS(SRNE) stock traded between a low of $0.00 and a high of $0.01. Shares are currently priced at $0.01, which is +59.5% above the low and 0.0% below the high.
The SORRENTO THERAPEUTICS(SRNE)'s current trading volume is 1.64M, compared to an average daily volume of 560.25K.
In the last year, SORRENTO THERAPEUTICS(SRNE) shares hit a 52-week high of $0.10 and a 52-week low of $0.00.
In the last year, SORRENTO THERAPEUTICS(SRNE) shares hit a 52-week high of $0.10 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.